(Q37039855)

17 August 2017

1 reference

title

Haematological toxicity of drugs used in psychiatry (English)

1 reference

17 August 2017

0 references

0 references

Robert J Flanagan

1

1 reference

PubMed ID

18098216

17 August 2017

Louisa Dunk

series ordinal

2

1 reference

17 August 2017

1 January 2008

1 reference

17 August 2017

Human Psychopharmacology

1 reference

17 August 2017

23 Suppl 1

1 reference

17 August 2017

27-41

1 reference

Congenital and acquired neutropenia

17 August 2017

1 reference

Hematologic side effects of psychotropics

21 January 2018

1 reference

Hematologic toxicity of sodium valproate

21 January 2018

1 reference

7 January 2021

Experience of maintaining clozapine medication in patients with 'red-alert zone' neutropenia: long-term follow-up results

1 reference

7 January 2021

Circadian rhythm of white blood cells during clozapine treatment

1 reference

7 January 2021

Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

1 reference

7 January 2021

Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients

1 reference

7 January 2021

Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland

1 reference

7 January 2021

Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect

1 reference

7 January 2021

Neutropenia Following Acute Chlorpromazine Ingestion

1 reference

7 January 2021

Eosinophilia after commencement of clozapine treatment

1 reference

7 January 2021

An alternative to interruption of treatment in recurrent clozapine-induced severe neutropenia

1 reference

7 January 2021

Reversible neutropenia during treatment with olanzapine: three case reports

1 reference

7 January 2021

Leukopenia and neutropenia induced by quetiapine.

1 reference

7 January 2021

Acute neutropenia in a patient treated with quetiapine

1 reference

7 January 2021

Antipsychotic drugs result in the formation of immature neutrophil leucocytes in schizophrenic patients

1 reference

7 January 2021

Formation of immature neutrophil leucocytes in schizophrenic patients treated with various antipsychotic drugs: comparisons and predictions

1 reference

7 January 2021

Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6

1 reference

7 January 2021

Psychotropic drug-induced neutropenia

1 reference

7 January 2021

Olanzapine-induced neutropenia: mechanism and treatment

1 reference

7 January 2021

Rechallenge with clozapine following leucopenia or neutropenia during previous therapy

1 reference

7 January 2021

Two-year follow-up of a patient with successful continuation of clozapine treatment despite morning pseudoneutropenia

1 reference

7 January 2021

Risperidone-induced morning pseudoneutropenia

1 reference

7 January 2021

Continuing clozapine treatment despite neutropenia

1 reference

7 January 2021

Successful initiation of clozapine treatment despite morning pseudoneutropenia

1 reference

7 January 2021

A review of clozapine safety

1 reference

7 January 2021

A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo

1 reference

7 January 2021

Hematological adverse events in clozapine-treated children and adolescents.

1 reference

7 January 2021

Paradoxical pattern of haematological risk with clozapine.

1 reference

7 January 2021

Haematological safety of antipsychotic drugs

1 reference

7 January 2021

Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis

1 reference

7 January 2021

Oxidation of clozapine and ascorbate by myeloperoxidase

1 reference

7 January 2021

Increased FasL expression correlates with apoptotic changes in granulocytes cultured with oxidized clozapine

1 reference

7 January 2021

Thrombotic thrombocytopenic purpura associated with quetiapine

1 reference

7 January 2021

Leukopenia in clozapine treated patients may be induced by other drugs: a case series

1 reference

7 January 2021

G-CSF plasma levels in clozapine-induced neutropenia

1 reference

7 January 2021

Lithium and clozapine rechallenge: a retrospective case analysis

1 reference

7 January 2021

Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

1 reference

7 January 2021

Clozapine underutilization and discontinuation in African Americans due to leucopenia

1 reference

7 January 2021

Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management.

1 reference

7 January 2021

Haematological safety of antipsychotic drugs

1 reference

7 January 2021

Eosinophilia indicating subclinical clozapine-induced pericarditis

1 reference

7 January 2021

A review of cyclic antidepressant-induced blood dyscrasias

1 reference

7 January 2021

1 reference

7 January 2021

Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis

1 reference

7 January 2021

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

1 reference

7 January 2021

Is it possible to distinguish between benign and malignant neutropenia in clozapine-treated patients by means of a hydrocortisone test?

1 reference

7 January 2021

Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis

1 reference

7 January 2021

Lithium-induced hematologic changes in patients with bipolar affective disorder

1 reference

7 January 2021

Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine

1 reference

7 January 2021

Sudden late onset of clozapine-induced agranulocytosis

1 reference

7 January 2021

Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy

1 reference

7 January 2021

Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.

1 reference

7 January 2021

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

1 reference

7 January 2021

In vitro toxicity of clozapine, olanzapine, and quetiapine on granulocyte-macrophage progenitors (GM-CFU).

1 reference

7 January 2021

Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development

1 reference

7 January 2021

Apparent neuroleptic malignant syndrome with clozapine and lithium

1 reference

7 January 2021

Diurnal variation of neutropenia during clozapine treatment

1 reference

7 January 2021

Clozapine, agranulocytosis, and benign ethnic neutropenia

1 reference

7 January 2021

SSRIs & the risk of abnormal bleeding

1 reference

7 January 2021

Prolongation of clozapine-induced leukopenia with olanzapine treatment

1 reference

7 January 2021

Psychotropic medications and leukopenia

1 reference

7 January 2021

Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?

1 reference

7 January 2021

A second trial of clozapine in a case of granulocytopenia

1 reference

7 January 2021

Risperidone-induced leucopenia and neutropenia: a case report

1 reference

7 January 2021

Clozapine-induced neutropenia in children: management with lithium carbonate

1 reference

7 January 2021

Olanzapine-induced leucopenia and neutropenia

1 reference

7 January 2021

Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia

1 reference

7 January 2021

Blood dyscrasias induced by psychotropic drugs.

1 reference

7 January 2021

Biochemical investigation of leukocyte functions during lithium therapy

1 reference

7 January 2021

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

1 reference

7 January 2021

Valproic acid-induced neutropenia

1 reference

7 January 2021

Increase in white blood cell count and serum sodium level following the addition of lithium to carbamazepine treatment among three chronically psychotic male patients with disturbed affective states.

1 reference

7 January 2021

Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis

1 reference

7 January 2021

Restarting clozapine after neutropenia: evaluating the possibilities and practicalities

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.917

1 reference

17 August 2017

1 reference

PubMed ID

18098216